UroGen Pharma's (URGN) shares fell 6% in recent Thursday trading after HC Wainwright downgraded the stock to neutral from buy.
Intraday volume topped 2.53 million shares versus the daily average of 939,720.
Price: 3.92, Change: -0.25, Percent Change: -6.00